Advertisement

Oral Sedation

  • Christopher Haxhi
  • Michael T. GoupilEmail author
Chapter

Abstract

Dental phobia can cause patient populations to avoid regular dental care throughout their lifetime. In this modern era, where, culturally, there is more emphasis on comfort, feelings, and avoiding situations that may be uncomfortable, the demand for sedation in dentistry and oral surgery has increased exponentially. This chapter is designed to familiarize clinicians with their sedation medication arsenal, the pharmacologic effects of these drugs, and techniques for safely providing oral sedation. The goal of oral sedation is to relieve dental phobia and increase compliance during the treatment time.

Keywords

Sedation General anesthesia Benzodiazepines Diazepam Alprazolam Midazolam Lorazepam Triazolam Promethazine Hydroxyzine 

References

  1. 1.
    Committee on Quality Management and Departmental Administration. 2019. Continuum of Depth of Sedation: Definition of General Anesthesia and Levels of Sedation/Analgesia | American Society of Anesthesiologists (ASA). [online] Asahq.org. Available at: https://www.asahq.org/standards-and-guidelines/continuum-of-depth-of-sedation-definition-of-general-anesthesia-and-levels-of-sedationanalgesia.
  2. 2.
    Matear D, Clarke D. Considerations for the use of oral sedation in the institutionalized geriatric patient during dental interventions: a review of the literature. Spec Care Dentist. 1999;19(2):56–63.  https://doi.org/10.1111/j.1754-4505.1999.tb01369.x.CrossRefPubMedGoogle Scholar
  3. 3.
    Gill CJ, Michaelides PL. Dental drugs and anaphylactic reactions: report of a case. Oral Surg Oral Med Oral Pathol. 1980;50:30.CrossRefGoogle Scholar
  4. 4.
    Becker D. Pharmacodynamic considerations for moderate and deep sedation. Anesth Prog. 2012;59(1):28–42.  https://doi.org/10.2344/0003-3006-59.1.28.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Malamed S. Sedation. 6th ed. St. Louis, MO: Elsevier; 2018. p. 100–14.Google Scholar
  6. 6.
    Tamargo J, Le Heuzey J, Mabo P. Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide. Eur J Clin Pharmacol. 2015;71(5):549–67.  https://doi.org/10.1007/s00228-015-1832-0.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Jacobi J, Fraser G, Coursin D, Riker R, Fontaine D, Wittbrodt E, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30(1):119–41.  https://doi.org/10.1097/00003246-200201000-00020.CrossRefPubMedGoogle Scholar
  8. 8.
    Donaldson M, Gizzarelli G, Chanpong B. Oral Sedation: a primer on anxiolysis for the adult patient. Anesth Prog. 2007;54(3):118–29.  https://doi.org/10.2344/0003-3006(2007)54[118:osapoa]2.0.co;2.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Darrouj J, Karma L, Arora R. Cardiovascular manifestations of sedatives and analgesics in the critical care unit. Am J Ther. 2009;16(4):339–53.  https://doi.org/10.1097/01.pap.0000249925.76324.47.CrossRefPubMedGoogle Scholar
  10. 10.
    Mancuso C, Tanzi M, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy. 2004;24(9):1177–85.  https://doi.org/10.1592/phco.24.13.1177.38089.CrossRefPubMedGoogle Scholar
  11. 11.
    Bounds CG, Nelson VL. Benzodiazepines. [Updated 2018 Nov 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470159/
  12. 12.
    Gudex C. Adverse effects of benzodiazepines. Soc Sci Med. 1991;33(5):587–96.  https://doi.org/10.1016/0277-9536(91)90216-y.CrossRefPubMedGoogle Scholar
  13. 13.
    McElhatton P. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol. 1994;8(6):461–75.  https://doi.org/10.1016/0890-6238(94)90029-9.CrossRefPubMedGoogle Scholar
  14. 14.
    Valium [package insert] South San Francisco, CA: Roche Pharmaceuticals Inc.; 2016.Google Scholar
  15. 15.
    Xanax [package insert] New York, NY: Pfizer Pharmaceuticals Inc.; 2011.Google Scholar
  16. 16.
    Smith M, Eadie M, Brophy T. The pharmacokinetics of midazolam in man. Eur J Clin Pharmacol. 1981;19(4):271–8.  https://doi.org/10.1007/bf00562804.CrossRefPubMedGoogle Scholar
  17. 17.
    Midazolam drug monograph, ClinicalKey. Elsevier. [Available at] www.ClinicalKey.com. Accessed 18 Jan 2019.
  18. 18.
    Ativan [package insert] Bridgewater, NJ: Valeant Pharmaceuticals North America LLC; 2016.Google Scholar
  19. 19.
    Halcion [package insert] New York, NY: Pfizer Pharmaceuticals Inc.; 2016.Google Scholar
  20. 20.
    Baroody F, Naclerio R. Antiallergic effects of H1-receptor antagonists. Allergy. 2000;55:17–27.  https://doi.org/10.1034/j.1398-9995.2000.00803.x.CrossRefPubMedGoogle Scholar
  21. 21.
    Reiner P, Kamondi A. Mechanisms of antihistamine-induced sedation in the human brain: H1 receptor activation reduces a background leakage potassium current. Neuroscience. 1994;59(3):579–88.  https://doi.org/10.1016/0306-4522(94)90178-3.CrossRefPubMedGoogle Scholar
  22. 22.
    Wright GZ, McAulay DJ. Current premedicating trends in pedodontics. J Dent Child. 1973;40:185–7.Google Scholar
  23. 23.
    Phenergan [package insert] Philadelphia, PA: Wyeth Pharmaceuticals Inc.Google Scholar
  24. 24.
    Vistaril [package insert] New York, NY: Pfizer Labs; 2014.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.UCLA Oral and Maxillofacial Surgery DepartmentLos AngelesUSA
  2. 2.University of Connecticut School of Dental MedicineFarmingtonUSA

Personalised recommendations